Figure 5

![Figure 5: Biological activity data for NSAID-derived compounds tested against Alzheimer's disease targets. The evaluation includes assessments of anti-inflammatory, antioxidant, or cholinesterase inhibitory properties.]()

> Source: Ivana Cacciatore et al. "Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer's Disease.." *International journal of molecular sciences*, 2016. PMID: [27376271](https://pubmed.ncbi.nlm.nih.gov/27376271/)

<figure>
  <img src="" alt="Biological activity data for NSAID-derived compounds tested against Alzheimer's disease targets. The evaluation includes assessments of anti-inflammatory, antioxidant, or cholinesterase inhibitory properties." />
  <figcaption>Figure 5. Biological activity data for NSAID-derived compounds tested against Alzheimer's disease targets. The evaluation includes assessments of anti-inflammatory, antioxidant, or cholinesterase inhibitory properties.<br>  Source: Ivana Cacciatore et al. "Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer's Disease.." <em>International journal of molecular sciences</em>, 2016. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/27376271/">27376271</a></figcaption>
</figure>